Cost Effectiveness of CEUS

In the last decade, contrast echocardiography (CE) media have rapidly evolved and are now widely used clinically to optimize ultrasound image quality. Several studies have shown that CE improves the assessment of global and regional left ventricular (LV) function, enhances the detec- tion of LV thrombi, and decreases variability of interpreta- tion (1–13). It has been estimated that 10% to 15% of routine echocardiograms have incomplete endocardial reso- lution, reaching 25% to 30% in critically ill patients in the intensive care unit (ICU) (14).

Although there is a wealth of information regarding the benefit of CE with regard to improving image quality and assessment of LV function, there are limited published data regarding the impact of contrast agents on patient manage- ment. The present study was therefore designed to prospec- tively evaluate the impact of contrast use on cardiac diag- nosis and management compared with noncontrast studies in a large cohort of consecutive patients who have under- gone both unenhanced and contrast-enhanced echocardio- grams as part of routine care.

For the full article, please view the attached paper from the Journal of the American College of Cardiology


ICUS Sponsors

ICUS gratefully acknowledges its 2017 sponsors:






Contact ICUS

  • Address:  International Contrast Ultrasound Society
    c/o Dentons
    233 S. Wacker Drive, Suite 5900 Chicago, IL 60606-6361
  • Telephone: 202-408-6199

About ICUS

ICUS is the world’s only professional society exclusively devoted to contrast-enhanced ultrasound (CEUS) medical imaging technology.

Learn more...

You are here: Home